Literature DB >> 25444825

Varicella vaccination coverage inverse correlation with varicella hospitalizations in Spain.

Ruth Gil-Prieto1, Laura Garcia-Garcia2, María San-Martin3, Angel Gil-de-Miguel2.   

Abstract

Varicella vaccines available in Spain were marketed in 1998 and 2003 for non-routine use. Since 2006 some regions included universal varicella vaccination in their regional routine vaccination programs at 15-18 months of age. Regions without universal vaccination in toddlers, but instead with the strategy of vaccinating susceptible adolescents, reached different varicella vaccination coverage through private market. This study shows the correlation between severe varicella zoster virus infections requiring hospitalization and the varicella vaccination coverage by region. A total of 3009 hospital discharges related to varicella were reported in 2009-2010. The overall annual rate of hospitalization was 3.27 cases per 100,000. In children younger than 5 years old varicella hospitalization rate was 30.73 cases per 100,000. Varicella related hospitalizations were significantly lower in the regions with universal vaccination. In those regions without universal vaccination at 15-18 months of age, those with higher coverage in private market showed lower hospitalization rates.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Coverage; Hospitalizations; Spain; Vaccine; Varicella

Mesh:

Substances:

Year:  2014        PMID: 25444825     DOI: 10.1016/j.vaccine.2014.10.076

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  5 in total

1.  Effectiveness and impact of a single-dose vaccine against chickenpox in the community of Madrid between 2001 and 2015.

Authors:  Pello Latasa; Angel Gil de Miguel; Maria Dolores Barranco Ordoñez; Inmaculada Rodero Garduño; Juan Carlos Sanz Moreno; María Ordobás Gavín; María Esteban Vasallo; Macarena Garrido-Estepa; Luis García-Comas
Journal:  Hum Vaccin Immunother       Date:  2018-06-22       Impact factor: 3.452

2.  Implementation of EACS vaccination recommendations among people living with HIV.

Authors:  Sven Breitschwerdt; Carolynne Schwarze-Zander; Ahmad Al Tayy; Julia Mutevelli; Jan-Christian Wasmuth; Jürgen K Rockstroh; Christoph Boesecke
Journal:  Infection       Date:  2022-05-06       Impact factor: 7.455

3.  Twenty Years of Medically-Attended Pediatric Varicella and Herpes Zoster in Ontario, Canada: A Population-Based Study.

Authors:  Anne E Wormsbecker; Jun Wang; Laura C Rosella; Jeffrey C Kwong; Chi Yon Seo; Natasha S Crowcroft; Shelley L Deeks
Journal:  PLoS One       Date:  2015-07-15       Impact factor: 3.240

Review 4.  The impact of varicella vaccination on varicella-related hospitalization rates: global data review.

Authors:  Maki Hirose; Alfredo Elias Gilio; Angela Esposito Ferronato; Selma Lopes Betta Ragazzi
Journal:  Rev Paul Pediatr       Date:  2016-02-17

5.  Evaluation of varicella vaccine effectiveness as public health tool for increasing scientific evidence and improving vaccination programs.

Authors:  Francesco Vitale; Emanuele Amodio
Journal:  J Pediatr (Rio J)       Date:  2020-06-30       Impact factor: 2.990

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.